Dixon Hubard Feinour & Brown’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $115K | Sell |
85,873
-1,700
| -2% | -$2.52K | 0.01% | 274 |
|
|
2022
Q1 | $185K | Hold |
87,573
| – | – | 0.02% | 299 |
|
|
2021
Q4 | $325K | Sell |
87,573
-3,854
| -4% | -$16.6K | 0.03% | 252 |
|
|
2021
Q3 | $456K | Hold |
91,427
| – | – | 0.1% | 123 |
|
|
2021
Q2 | $596K | Sell |
91,427
-83,661
| -48% | -$585K | 0.12% | 111 |
|
|
2021
Q1 | $909K | Buy |
175,088
+87,544
| +100% | +$740K | 0.11% | 116 |
|
|
2020
Q4 | $306K | Hold |
87,544
| – | – | 0.08% | 134 |
|
|
2020
Q3 | $306K | Hold |
87,544
| – | – | 0.08% | 134 |
|
|
2020
Q2 | $369K | Hold |
87,544
| – | – | 0.1% | 118 |
|
|
2020
Q1 | $298K | Buy |
87,544
+1,000
| +1% | +$4.32K | 0.1% | 115 |
|
|
2019
Q4 | $474K | Hold |
86,544
| – | – | 0.12% | 112 |
|
|
2019
Q3 | $495K | Hold |
86,544
| – | – | 0.14% | 107 |
|
|
2019
Q2 | $663K | Hold |
86,544
| – | – | 0.19% | 101 |
|
|
2019
Q1 | $455K | Hold |
86,544
| – | – | 0.14% | 109 |
|
|
2018
Q4 | $566K | Buy |
86,544
+600
| +0.7% | +$6.72K | 0.21% | 94 |
|
|
2018
Q3 | $1.48M | Hold |
85,944
| – | – | 0.41% | 64 |
|
|
2018
Q2 | $1.2M | Hold |
85,944
| – | – | 0.35% | 68 |
|
|
2018
Q1 | $1.32M | Hold |
85,944
| – | – | 0.37% | 70 |
|
|
2017
Q4 | $990K | Buy |
85,944
+16,393
| +24% | +$244K | 0.27% | 90 |
|
|
2017
Q3 | $1.32M | Sell |
69,551
-1,053
| -1% | -$21.7K | 0.38% | 72 |
|
|
2017
Q2 | $1.7M | Sell |
70,604
-745
| -1% | -$16.3K | 0.49% | 61 |
|
|
2017
Q1 | $1.41M | Sell |
71,349
-642
| -0.9% | -$14.3K | 0.42% | 68 |
|
|
2016
Q4 | $1.73M | Sell |
71,991
-266
| -0.4% | -$7.41K | 0.55% | 55 |
|
|
2016
Q3 | $2.01M | Buy |
72,257
+8,357
| +13% | +$221K | 0.62% | 47 |
|
|
2016
Q2 | $1.56M | Hold |
63,900
| – | – | 0.5% | 57 |
|
|
2016
Q1 | $1.69M | Sell |
63,900
-277
| -0.4% | -$8.72K | 0.55% | 51 |
|
|
2015
Q4 | $1.92M | Buy |
64,177
+100
| +0.2% | +$3.37K | 0.61% | 46 |
|
|
2015
Q3 | $2.02M | Sell |
64,077
-689
| -1% | -$33.6K | 0.74% | 40 |
|
|
2015
Q2 | $3.13M | Sell |
64,766
-2,463
| -4% | -$104K | 0.96% | 34 |
|
|
2015
Q1 | $2.92M | Buy |
67,229
+11,323
| +20% | +$407K | 0.86% | 38 |
|
|
2014
Q4 | $1.47M | Hold |
55,906
| – | – | 0.46% | 63 |
|
|
2014
Q3 | $993K | Sell |
55,906
-4,185
| -7% | -$85.4K | 0.33% | 84 |
|
|
2014
Q2 | $1.44M | Sell |
60,091
-4,185
| -7% | -$84.8K | 0.47% | 59 |
|
|
2014
Q1 | $1.61M | Buy |
+64,276
| New | +$1.78M | 0.56% | 52 |
|
Other funds holding PGEN
TS
MVP
IAM
Dixon Hubard Feinour & Brown's PGEN Position: Q2 2022 in Review
Dixon Hubard Feinour & Brown reduced its Precigen (PGEN) stake by 1.9% in Q2 2022, selling an estimated $2.52K and leaving 85,873 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #274.
Dixon Hubard Feinour & Brown first reported a position in PGEN in Q1 2014 and has held it in 34 quarters since. The position peaked at $3.13M in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.
- Dixon Hubard Feinour & Brown held 85,873 shares of Precigen worth $115K as of Q2 2022.
- Dixon Hubard Feinour & Brown sold 1,700 Precigen shares in Q2 2022, an estimated $2.52K.
- Precigen made up 0.01% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #274 holding.
- Dixon Hubard Feinour & Brown first reported a position in Precigen in Q1 2014 and has held it in 34 quarters since.
- Dixon Hubard Feinour & Brown's Precigen position peaked at $3.13M in Q2 2015.
- 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.